Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-24

Clinical Trial Update: Combined Bitter Melon Extract and Snakehead Fish Powder Supplementation for Glycemic Control in Type 2 Diabetes [NA]

View source ↗

Summary

A clinical trial is evaluating the combination of bitter melon extract and snakehead fish powder to improve glycemic control in Type 2 Diabetes; the study is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bitter melon extract (Momordica charantia extract)
  • Snakehead fish powder (Channa argus powder)

Snippet

Sponsor: Universitas Muhammadiyah Surakarta | Conditions: Type 2 Diabetes Mellitus (T2DM), Hyperglycemia | NA | Status: NOT_YET_RECRUITING